[
  {
    "": 0,
    "Gene name": "C2",
    "Genomic Position": "6:31895254-31913449(+)",
    "CDS Mutation": "c.3532C>T",
    "AA Mutation": "p.Q1178*",
    "Disease": "Thyroid Gland Carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:25295501"
  },
  {
    "": 1,
    "Gene name": "TSC2",
    "Genomic Position": "16:2097466-2138713(+)",
    "CDS Mutation": "c.3532C>T",
    "AA Mutation": "p.Q1178*",
    "Disease": "Thyroid Gland Carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Everolimus",
    "Description": "",
    "rs value": 45517297,
    "pmid": "PubMed:25295501"
  },
  {
    "": 2,
    "Gene name": "GNAS",
    "Genomic Position": "20:57427769-57486247(+)",
    "CDS Mutation": "R201H",
    "AA Mutation": "p.R201H",
    "Disease": "Thyroid Gland Follicular Carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Radioactive Iodine",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26788326"
  },
  {
    "": 3,
    "Gene name": "ALK",
    "Genomic Position": "2:29415640-30144432(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / anaplastic carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Crizotinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:24687827"
  },
  {
    "": 4,
    "Gene name": "ALK",
    "Genomic Position": "2:29415640-30144432(-)",
    "CDS Mutation": "Fusion",
    "AA Mutation": "Fusion",
    "Disease": "Thyroid Gland Anaplastic Carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Crizotinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:24687827"
  },
  {
    "": 5,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:29320312"
  },
  {
    "": 6,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "Thyroid Gland Anaplastic Carcinoma",
    "therapy_rank": 2,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 7,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 2,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 8,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "V600E/K",
    "AA Mutation": "p.V600E/K",
    "Disease": "thyroid / carcinoma / anaplastic carcinoma",
    "therapy_rank": 2,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:29320312"
  },
  {
    "": 9,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "thyroid / carcinoma / anaplastic carcinoma",
    "therapy_rank": 2,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 10,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "thyroid / carcinoma / papillary carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 11,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "Thyroid Gland Papillary Carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 12,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "Thyroid Gland Anaplastic Carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 13,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "V600E/M",
    "AA Mutation": "p.V600E/M",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:29320312"
  },
  {
    "": 14,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "thyroid / carcinoma / anaplastic carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 15,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1798delinsTACA",
    "AA Mutation": "p.V600",
    "Disease": "thyroid / carcinoma / anaplastic carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:29320312"
  },
  {
    "": 16,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 17,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "Thyroid Gland Papillary Carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 18,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "Thyroid Gland Anaplastic Carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 19,
    "Gene name": "MTOR",
    "Genomic Position": "1:11166592-11322564(-)",
    "CDS Mutation": "c.6324C>A",
    "AA Mutation": "p.F2108L",
    "Disease": "Thyroid Gland Carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Resistance",
    "Therapies": "Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:25295501"
  },
  {
    "": 20,
    "Gene name": "MTOR",
    "Genomic Position": "1:11166592-11322564(-)",
    "CDS Mutation": "c.939C>A",
    "AA Mutation": "p.F313L",
    "Disease": "anaplastic_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:25295501"
  },
  {
    "": 21,
    "Gene name": "MTOR",
    "Genomic Position": "1:11166592-11322564(-)",
    "CDS Mutation": "c.6324C>A",
    "AA Mutation": "p.F2108L",
    "Disease": "anaplastic_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:25295501"
  },
  {
    "": 22,
    "Gene name": "RET",
    "Genomic Position": "10:43572475-43625799(+)",
    "CDS Mutation": "c.2753T>C",
    "AA Mutation": "p.M918T",
    "Disease": "Thyroid Gland Medullary Carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Selpercatinib",
    "Description": "",
    "rs value": 74799832,
    "pmid": "PubMed:nan"
  },
  {
    "": 23,
    "Gene name": "RET",
    "Genomic Position": "10:43572475-43625799(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / medullary carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Selpercatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:nan"
  },
  {
    "": 24,
    "Gene name": "RET",
    "Genomic Position": "10:43572475-43625799(+)",
    "CDS Mutation": "c.1900T>C",
    "AA Mutation": "p.C634R",
    "Disease": "thyroid / carcinoma / medullary carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Selpercatinib",
    "Description": "",
    "rs value": "75076352'], 'CLNDISDBINCL'MONDO:MONDO:0008234', 'MeSH:D018813', 'MedGen:C0025268', 'OMIM:171400', 'Orphanet:ORPHA247698', 'SNOMED_CT:61808009'], 'CLNDNINCL'Multiple_endocrine_neoplasia', '_type_2a'], 'CLNSIGINCL'13906:Pathogenic",
    "pmid": "PubMed:nan"
  },
  {
    "": 25,
    "Gene name": "RET",
    "Genomic Position": "10:43572475-43625799(+)",
    "CDS Mutation": "c.2753T>C",
    "AA Mutation": "p.M918T",
    "Disease": "thyroid / carcinoma / medullary carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Selpercatinib",
    "Description": "",
    "rs value": 74799832,
    "pmid": "PubMed:nan"
  },
  {
    "": 26,
    "Gene name": "RET",
    "Genomic Position": "10:43572475-43625799(+)",
    "CDS Mutation": "fusions",
    "AA Mutation": "fusions",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Selpercatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:nan"
  },
  {
    "": 27,
    "Gene name": "RET",
    "Genomic Position": "10:43572475-43625799(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / medullary carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Selpercatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:nan"
  },
  {
    "": 28,
    "Gene name": "RET",
    "Genomic Position": "10:43572475-43625799(+)",
    "CDS Mutation": "c.2753T>C",
    "AA Mutation": "p.M918T",
    "Disease": "Thyroid Gland Medullary Carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Selpercatinib",
    "Description": "",
    "rs value": 74799832,
    "pmid": "PubMed:nan"
  },
  {
    "": 29,
    "Gene name": "RET",
    "Genomic Position": "10:43572475-43625799(+)",
    "CDS Mutation": "c.2753T>C",
    "AA Mutation": "p.M918T",
    "Disease": "thyroid / carcinoma / medullary carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Selpercatinib",
    "Description": "",
    "rs value": 74799832,
    "pmid": "PubMed:nan"
  },
  {
    "": 30,
    "Gene name": "RET",
    "Genomic Position": "10:43572475-43625799(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Selpercatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:nan"
  },
  {
    "": 31,
    "Gene name": "RET",
    "Genomic Position": "10:43572475-43625799(+)",
    "CDS Mutation": "V804M_or_RET_M918T",
    "AA Mutation": "p.V804M_or_RET_M918T",
    "Disease": "thyroid / carcinoma / medullary carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Selpercatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:nan"
  },
  {
    "": 32,
    "Gene name": "RET",
    "Genomic Position": "10:43572475-43625799(+)",
    "CDS Mutation": "fusion_COSF1231",
    "AA Mutation": "fusion_COSF1231",
    "Disease": "thyroid / carcinoma / medullary carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Selpercatinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:nan"
  },
  {
    "": 33,
    "Gene name": "F2",
    "Genomic Position": "11:46740730-46761056(+)",
    "CDS Mutation": "c.6324C>A",
    "AA Mutation": "p.F2108L",
    "Disease": "Thyroid Gland Carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Resistance",
    "Therapies": "Everolimus",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:25295501"
  },
  {
    "": 34,
    "Gene name": "HRAS",
    "Genomic Position": "11:532243-535550(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Tipifarnib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT02383927"
  },
  {
    "": 35,
    "Gene name": "FGFR1",
    "Genomic Position": "8:38268656-38325363(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pazopanib",
    "Description": "",
    "rs value": "",
    "pmid": "DOI:NCT01813136"
  },
  {
    "": 36,
    "Gene name": "NTRK1",
    "Genomic Position": "1:156830686-156851434(+)",
    "CDS Mutation": "fusions_or_NTRK2_fusions_or_NTRK3_fusions",
    "AA Mutation": "fusions_or_NTRK2_fusions_or_NTRK3_fusions",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 2,
    "Response to Drug": "Sensitivity",
    "Therapies": "Taletrectinib",
    "Description": "",
    "rs value": "",
    "pmid": "DOI:NCT02279433"
  },
  {
    "": 37,
    "Gene name": "NTRK1",
    "Genomic Position": "1:156830686-156851434(+)",
    "CDS Mutation": "fusions",
    "AA Mutation": "fusions",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Taletrectinib",
    "Description": "",
    "rs value": "",
    "pmid": "DOI:NCT02279433"
  },
  {
    "": 38,
    "Gene name": "CD274",
    "Genomic Position": "9:5450525-5470547(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Cabozantinib + Ipilimumab + Nivolumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT03914300"
  },
  {
    "": 39,
    "Gene name": "CD274",
    "Genomic Position": "9:5450525-5470547(+)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Cabozantinib + Ipilimumab + Nivolumab",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT03914300"
  },
  {
    "": 40,
    "Gene name": "TP53",
    "Genomic Position": "17:7571720-7590856(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / anaplastic carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Cisplatin + Crolibulin",
    "Description": "",
    "rs value": "",
    "pmid": "DOI:NCT01240590"
  },
  {
    "": 41,
    "Gene name": "KRAS",
    "Genomic Position": "12:25362365-25403737(-)",
    "CDS Mutation": "G12_or_HRAS_G13_or_HRAS_Q61_or_KRAS_G12_or_KRAS_G13_or_KRAS_Q61_or_NRAS_G12_or_NRAS_G13_or_NRAS_Q61",
    "AA Mutation": "p.G12_or_HRAS_G13_or_HRAS_Q61_or_KRAS_G12_or_KRAS_G13_or_KRAS_Q61_or_NRAS_G12_or_NRAS_G13_or_NRAS_Q61",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 2,
    "Response to Drug": "Sensitivity",
    "Therapies": "Radioiodine + Trametinib",
    "Description": "",
    "rs value": "",
    "pmid": "DOI:NCT02152995"
  },
  {
    "": 42,
    "Gene name": "NRAS",
    "Genomic Position": "1:115247090-115259515(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Vemurafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30036146"
  },
  {
    "": 43,
    "Gene name": "NRAS",
    "Genomic Position": "1:115247090-115259515(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 2,
    "Response to Drug": "Sensitivity",
    "Therapies": "Vemurafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30036146"
  },
  {
    "": 44,
    "Gene name": "NRAS",
    "Genomic Position": "1:115247090-115259515(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Vemurafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30036146"
  },
  {
    "": 45,
    "Gene name": "NRAS",
    "Genomic Position": "1:115247090-115259515(-)",
    "CDS Mutation": "c.?",
    "AA Mutation": "p.Q61K",
    "Disease": "papillary_carcinoma",
    "therapy_rank": 1,
    "Response to Drug": "Resistance",
    "Therapies": "Vemurafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:30036146"
  }
]
